The effects of levofloxacin on rabbit anterior cruciate ligament cells in vitro

Toxicology and Applied Pharmacology

Volumn 257, Issue 1, 2011, Pages 67-73

  Deng, Yu ^a   Chen, Biao ^a   Qi, Yongjian ^a   Magdalou, Jacques ^c   Wang, Hui ^b   Chen, Liaobin ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c Biopôle de l Université de Lorraine   (France)

Author keywords

Anterior cruciate ligament; Caspase 3; Cytotoxicity; Levofloxacin; Matrix metalloproteinases

Indexed keywords

BETA ACTIN; CASPASE 3; COLLAGEN TYPE 1; COLLAGENASE 3; LEVOFLOXACIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTERIOR CRUCIATE LIGAMENT; APOPTOSIS; ARTICLE; CELL DEGENERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MICROSCOPY, ELECTRON, TRANSMISSION; OFLOXACIN; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ORYCTOLAGUS CUNICULUS;

EID: 81255146421     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.08.019     Document Type: Article

References (31)

1. Benjamin M., Ralphs J.R. The cell and developmental biology of tendons and ligaments. Int. Rev. Cytol. 2000, 196:85-130.
2. Bernard-Beaubois K., Hecquet C., Hayem G., Rat P., Adolphe M. In vitro study of cytotoxicity of quinolones on rabbit tenocytes. Cell Biol. Toxicol 1998, 14:283-292.
3. Beye J.A., Hart D.A., Bray R.C., McDougall J.J., Salo P.T. Injury-induced changes in mRNA levels differ widely between anterior cruciate ligament and medial collateral ligament. Am. J. Sports Med. 2008, 36:1337-1346.
4. Bray R.C., Leonard C.A., Salo P.T. Vascular physiology and long-term healing of partial ligament tears. J. Orthop. Res. 2002, 20:984-989.
5. Carroll D.N., Carroll D.G. Interactions between warfarin and three commonly prescribed fluoroquinolones. Ann. Pharmacother. 2008, 42:680-685.
6. Corps A.N., Harrall R.L., Curry V.A., Fenwick S.A., Hazleman B.L., Riley G.P. Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum. 2002, 46:3034-3040.
7. Corps A.N., Harrall R.L., Curry V.A., Hazleman B.L., Riley G.P. Contrasting effects of fluoroquinolone antibiotics on the expression of the collagenases, matrix metalloproteinases (MMP)-1 and -13, in human tendon-derived cells. Rheumatology (Oxford) 2005, 44:1514-1517.
8. De Sarro A., De Sarro G. Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr. Med. Chem. 2001, 8:371-384.
9. Diegelmann R.F., Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci. 2004, 9:283-289.
10. Foos M.J., Hickox J.R., Mansour P.G., Slauterbeck J.R., Hardy D.M. Expression of matrix metalloprotease and tissue inhibitor of metalloprotease genes in human anterior cruciate ligament. J. Orthop. Res. 2001, 19:642-649.
11. Henriet P., Blavier L., Declerck Y.A. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. APMIS 1999, 107:111-119.
12. Hoffmann A., Gross G. Tendon and ligament engineering in the adult organism: mesenchymal stem cells and gene-therapeutic approaches. Int. Orthop. 2007, 31:791-797.
13. Kappel E.M., Shakibaei M., Bello A., Stahlmann R. Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats. Antimicrob. Agents Chemother. 2002, 46:3320-3322.
14. Kato M., Takada S., Kashida Y., Nomura M. Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats. Toxicol. Pathol. 1995, 23:385-392.
15. Kowatari K., Nakashima K., Ono A., Yoshihara M., Amano M., Toh S. Levofloxacin-induced bilateral Achilles tendon rupture: a case report and review of the literature. J. Orthop. Sci. 2004, 9:186-190.
16. Lo I.K., Marchuk L., Hart D.A., Frank C.B. Messenger ribonucleic acid levels in disrupted human anterior cruciate ligaments. Clin. Orthop. Relat. Res. 2003, 249-258.
17. Majima T., Irie T., Sawaguchi N., Funakoshi T., Iwasaki N., Harada K., Minami A., Nishimura S.I. Chitosan-based hyaluronan hybrid polymer fibre scaffold for ligament and tendon tissue engineering. Proceedings of the Institution of Mechanical Engineers. Proc. Inst. Mech. Eng. H 2007, 221:537-546.
18. Mathis A.S., Chan V., Gryszkiewicz M., Adamson R.T., Friedman G.S. Levofloxacin-associated Achilles tendon rupture. Ann. Pharmacother. 2003, 37:1014-1017.
19. Movin T., Gad A., Guntner P., Foldhazy Z., Rolf C. Pathology of the Achilles tendon in association with ciprofloxacin treatment. Foot Ankle Int. 1997, 18:297-299.
20. Oliphant C.M., Green G.M. Quinolones: a comprehensive review. Am. Fam. Physician 2002, 65:455-464.
21. Raza S.L., Cornelius L.A. Matrix metalloproteinases: pro- and anti-angiogenic activities. J. Investig. Dermatol. Symp. Proc. 2000, 5:47-54.
22. Raza S.L., Cornelius L.A. Matrix metalloproteinases and their native or pharmacologic inhibitors. Adv. Dermatol. 2000, 16:185-208. (discussion 209).
23. Sendzik J., Shakibaei M., Schafer-Korting M., Stahlmann R. Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology 2005, 212:24-36.
24. Shakibaei M., Stahlmann R. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Arch. Toxicol. 2001, 75:97-102.
25. Slauterbeck J.R., Hickox J.R., Beynnon B., Hardy D.M. Anterior cruciate ligament biology and its relationship to injury forces. Orthop. Clin. North Am. 2006, 37:585-591.
26. Stahlmann R. Clinical toxicological aspects of fluoroquinolones. Toxicol. Lett. 2002, 127:269-277.
27. Tozer S., Duprez D. Tendon and ligament: development, repair and disease. Birth Defects Res. C Embryo Today 2005, 75:226-236.
28. Tsai W.C., Hsu C.C., Tang F.T., Wong A.M., Chen Y.C., Pang J.H. Ciprofloxacin-mediated cell proliferation inhibition and G2/M cell cycle arrest in rat tendon cells. Arthritis Rheum. 2008, 58:1657-1663.
29. Tsai W.C., Hsu C.C., Chen C.P., Chang H.N., Wong A.M., Lin M.S., Pang J.H. Ciprofloxacin up-regulates tendon cells to express matrix metalloproteinase-2 with degradation of type I collagen. J. Orthop. Res. 2011, 29:67-73.
30. Williams R.J., Attia E., Wickiewicz T.L., Hannafin J.A. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am. J. Sports Med. 2000, 28:364-369.
31. Yuan J., Murrell G.A., Wei A.Q., Wang M.X. Apoptosis in rotator cuff tendonopathy. J. Orthop. Res. 2002, 20:1372-1379.